Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting

Ads

You May Also Like

MacroGenics Announces Participation in Two Upcoming Investor Conferences

ROCKVILLE, MD, Sept. 26, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

Neal Ryan, M.D. Heads New Leadership Team at Askesis Development Group

PITTSBURGH, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Askesis Development Group and its EHR, PsychConsult® ...

Celldex Therapeutics Presents Phase 1 Study of Varlilumab and Opdivo® at 2017 ASCO Annual Meeting

HAMPTON, N.J., June 05, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today ...